Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer

The epidermal growth factor receptor (EGFR) is overexpressed in the majority of non-small cell lung cancers (NSCLC) and is a major target for new therapies. Specific EGFR tyrosine kinase inhibitors (TKIs) have been developed and used for the treatment of advanced NSCLC. The clinical response, howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaozhu, Chang, Alex
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467518/
https://www.ncbi.nlm.nih.gov/pubmed/18645621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467518/
https://www.ncbi.nlm.nih.gov/pubmed/18645621

Ejemplares similares